Trial of Homeopathy on Management of Menorrhagia

Pilot Study of Homeopathy in Dysfunctional Uterine Bleeding Presenting as Menorrhagia

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01460043

Enrollment

Registered

2011-10-26

Start date

2008-06-30

Completion date

2009-06-30

Last updated

2011-11-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menorrhagia

Brief summary

The purpose of this study is to compare outcomes and quality-of-life issues in the treatment of menorrhagia, this randomized double blind controlled trial compared homeopathy and placebo. Clinical criteria were confirmed the diagnosis, and subjective assessment of the condition was performed during one pre-treatment and three treatment cycles. outcome measures were bleeding days, intensity. average pads used during menstrual cycle, abdominal & back pain, General health and overall satisfaction.

Interventions

DRUGHomeopathy

Each homeopathic medication was given as 1 g dose of homeopathic preparation in 30c potency. The dose is prepared as lactose globules on which the homeopathic preparation.

DRUGplacebo

corresponding placebo was identical in appearance of homeopathic globule prepared in alcohol.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender

FEMALE

Age

35 Years to 49 Years

Healthy volunteers

Inclusion criteria

* Age between 35-49 years with regular heavy menstrual bleeding * menstrual loss requiring more than 5 Pads/tampons per day * menstrual cycle longer than 6 days

Exclusion criteria

* Organic causes of menorrhagia * History of renal or hepatic impairment, * Endocrine disorder including diabetes, thyroidism * Thromboembolic disease, * Inflammatory bowel disease, * Peptic or intestinal ulceration, or coagulation or fibrinolytic disorders and --Malignancy.

Design outcomes

Primary

Measure	Time frame	Description
daily assessment of bleeding	change from baseline over 3 months	bleeding days, intensity of bleeding, average pads used, back and abdominal pain associated.daily assessment during menses were completed by participants at baseline before randomization and at each menses for 3 month of intervention period.

Secondary

Measure	Time frame
Health related quality of life	change from baseline over 3 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026